Transcatheter pulmonary valve replacement after pulmonary homograft dysfunction

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Interventional Cardiology

Background:

• Pulmonary homograft dysfunction presents a significant clinical challenge, particularly in patients with prior Ross procedures.
• Reoperation for pulmonary homograft failure is associated with high morbidity and mortality rates.

Observation:

• A case of early, severe pulmonary homograft stenosis was identified 18 months post-Ross procedure.

Findings:

• Successful management of early severe pulmonary homograft stenosis was achieved using transcatheter pulmonary valve replacement (TPVR).
• TPVR provided a less invasive alternative to reoperation for this complex patient.

Implications:

• Transcatheter pulmonary valve replacement is a viable and effective treatment option for early pulmonary homograft stenosis following a Ross procedure.
• This approach may reduce the need for conventional reoperation, thereby improving patient outcomes and lowering healthcare costs.